Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 86 citing Stephens: Sporadic meningococcal disease in adults: results of a 5-year population-based study. (0.08 sec) 

Meningococcal disease


NE Rosenstein, BA Perkins, DS Stephens, T … - The New England …, 2001 - nejm.highwire.org
Since 1960, rates of meningococcal disease in the United States have remained relatively
stable, at approximately 0.9 to 1.5 cases per 100,000 population per year, or 2500 to 3000 cases
per year. 5 Meningococcal disease occurs year-round, but the majority of cases occur ...
Cited by 511 - Related articles - BL Direct - All 7 versions

Update on meningococcal disease with emphasis on pathogenesis and clinical …

- angrylapdog.com
M Van Deuren, P Brandtzaeg, JWM van der … - Clinical Microbiology …, 2000 - cmr.highwire.org
The only natural reservoir of Neisseria meningitidis is the human nasopharyngeal mucosa. Depending
on age, climate, country, socioeconomic status, and other factors, approximately 10% of the human
population harbors meningococci in the nose. However, invasive disease is relatively ...
Cited by 365 - Related articles - BL Direct - All 10 versions

Prevention and control of meningococcal disease


OO Bilukha, N Rosenstein - Recommendations of the Advisory Comitte on … - cdc.gov
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine
([MCV4] Menactra,™ manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed
for use among persons aged 11--55 years. CDC's Advisory Committee on Immunization ...
Cited by 190 - Related articles - Cached - All 3 versions

Tobacco smoke as a risk factor for meningococcal disease


M Fischer, K Hedberg, P Cardosi, BD Plikaytis … - The Pediatric …, 1997 - journals.lww.com
From the Childhood and Respiratory Diseases Branch, Division of Bacterial and Mycotic
Diseases, National Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, GA (MF, BDP, JDW, BAP); Oregon Health Division, Portland, OR (KH, ...
Cited by 116 - Related articles - BL Direct - All 4 versions

Epidemiology and pathogenesis of Neisseria meningitidis


YL Tzeng, DS Stephens - Microbes and Infection, 2000 - Elsevier
N. meningitidis is unique among the major bacterial agents of meningitis in that it causes epidemic
as well as endemic (sporadic) disease. The African meningitis belt (eg, sub Saharan Africa) continues
to have major outbreaks of meningococcal disease [1 and 2]. During African epidemics, ...
Cited by 103 - Related articles - All 5 versions

Invasive meningococcal disease in adolescents and young adults

- angrylapdog.com
LH Harrison, MA Pass, AB … - … : The Journal of …, 2001 - jama.ama-assn.org.p.angrylapdog. …
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 96 - Related articles - Cached - BL Direct - All 4 versions

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

- sepeap.org [PDF] 
DS Stephens, B Greenwood, P Brandtzaeg - The Lancet, 2007 - Elsevier
Meningococcus, an obligate human bacterial pathogen, remains a worldwide and devastating
cause of epidemic meningitis and sepsis. However, advances have been made in our understanding
of meningococcal biology and pathogenesis, global epidemiology, transmission and ...
Cited by 93 - Related articles - All 22 versions

Prospects for vaccine prevention of meningococcal infection

- angrylapdog.com
LH Harrison - Clinical microbiology reviews, 2006 - cmr.asm.org.p.angrylapdog.com
Neisseria meningitidis is the leading cause of bacterial meningitis in the United States and
worldwide. A serogroup A/C/W-135/Y polysaccharide meningococcal vaccine has been licensed
in the United States since 1981 but has not been used universally outside of the military. ...
Cited by 57 - Related articles - BL Direct - All 11 versions

Serogroup Y meningococcal disease in Chicago, 1991-1997


JA Racoosin, CG Whitney, CS Conover, PS Diaz - Jama, 1998 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context.— In 1994, surveillance by the Chicago ...
Cited by 54 - Related articles - BL Direct - All 4 versions

The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB …


M Mahbubur Rahman, DS Stephens, CM Kahler, J … - Carbohydrate Research, 1998 - Elsevier
The complete structure of the lipooligosaccharide (LOS) from Neisseria meningitidis strain NMB
(serotype 2b:P1.2,5), a serogroup B cerebrospinal fluid isolate, was determined. Two oligosaccharide
(OS) fractions and lipid-A were obtained following mild acid hydrolysis of the LOS. The ...
Cited by 43 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google